Genes, environment, and orofacial clefting: N-acetyltransferase and folic acid

Journal of Craniofacial Surgery

Volumn 21, Issue 5, 2010, Pages 1384-1387

  Erickson, Robert P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

6 aminonicotinamide; folic acid; hydrocortisone; Mouse models; N acetyltransferase; orofacial clefting; phenytoin

Indexed keywords

6 AMINONICOTINAMIDE; ARYLAMINE ACETYLTRANSFERASE; FOLIC ACID; HYDROCORTISONE; NAT2 ENZYME, MOUSE; PHENYTOIN;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CLEFT LIP; CLEFT PALATE; DISEASE MODEL; DNA METHYLATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOUSE; MOUSE STRAIN; POLYMERASE CHAIN REACTION; RISK FACTOR;

6-AMINONICOTINAMIDE; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CLEFT LIP; CLEFT PALATE; DISEASE MODELS, ANIMAL; DNA METHYLATION; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HYDROCORTISONE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; PHENYTOIN; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 77957326907     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181ec6992     Document Type: Article

References (52)

1. Ching CHS, Chung CS A genetic study of cleft lip and palate in Hawaii. I. Interracial crosses. Am J Hum Genet 1974;26:162-176
2. WHO Scientific Group. Genetic factors in congenital malformations: report of a WHO scientific Group. World Health Organ Tech Rep Ser 1970;438:11-17
3. Rahimov F, Marazita ML, Visel A, et al. Disruption of an AP-2a binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet 2008;40:1341-1347
4. Birnbaum S, Ludwig KU, Reuter H, et al. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat Genet 2009;41:473-477
5. Shi M, Mostowska A, Jugessur A., et al. Identification of microdeletions in candidate genes for cleft lip and/or palate. Birth Defects Res A 2009;85:42-51
6. Suzuki S, Marazita ML, Cooper M.E., et al. Mutations in BMP4 are associated with subepithelial, microform, and overt cleft lip. Am J Hum Genet 2009;84:406-411
7. Juriloff DM, Harris MJ Mouse genetic models of cleft lip with or without cleft palate. Birth Defects Res A 2008;82:63-77
8. Bonner JJ, Slavkin HC Cleft palate susceptibility linked to histocompatibility-2 (H-2) in the mouse. Immunogenetics 1975;2: 213-217
9. Erickson RP, Butley MS, Sing CF H-2 and non-H-2-determined strain variation in palatal shelf and tongue adenosine 3':5' cyclic monophosphate. J Immunogenet 1979;6:253-262
10. Butley MS, Erickson RP, Pratt WB Hepatic glucocorticoid receptors and the H-2 locus. Nature 1978;275:136-138
11. Leach KL, Erickson RP, Pratt WB The endogenous heat-stable glucocorticoid receptor stabilizing factor and the H-2 locus. J Steroid Biochem 1982;17:121-123
12. Harper KJ, Erickson RP Ionic effects on strain differences in hepatic cytosolic glucocorticoid receptor levels in mice. Teratology 1983;27: 43-49
13. Pairitz G, Erickson RP, Schultz J, et al. Failure to detect association of isolated cleft palate with HLA antigens. J Immunogenet 1985;12: 259-262
14. Erickson, RP, Karolyi, IJ, Diehl, S, Correlation of susceptibility to 6-aminonicontinamide and hydrocortisone-induced cleft palate. Life Sci 2005;76:2071-2078
15. Rawles LA, Acuna D, Erickson, RP. The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Mol Reprod Dev 2007;74:1483-1489
16. Weber WW. The Acetylator Genes and Drug Response. New York: Oxford University Press, 1987:1-248
17. Karolyi J, Erickson RP, Liu S, et al. Major effects on teratogen-induced facial clefting in mice determined by a single genetic region. Genetics 1990;126:201-205
18. Diehl SR, Erickson RP Genome scan for teratogen-induced clefting susceptibility loci in the mouse: evidence of both allelic and locus heterogeneity distinguishing cleft lip and cleft palate. Proc Natl Acad Sci 1997;94:5231-5236
19. Atlas SA, Zweier JL, Nebert DW Genetic differences in phenytoin pharmacokinetics in vivo clearance and in vitro metabolism among inbred strains of mice. Dev Pharmacol Ther 1980;1:281-304
20. Erickson RP, Cao W, Acuna D.K., et al. Confirmation of the Role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts. Mol Reprod Dev 2008;75:1071-1076
21. Mattano SS, Erickson RP, Nesbitt M.N., et al. Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. J Heredity 1988;79:430-433
22. Minchin RF. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochemistry 1995;307:1-3
23. Ward A, Summers MJ, Sim E. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 1995;49:1759-1767
24. Briggs RM. Vitamin supplementation as a possible factor in the incidence of cleft lip/palate deformities in humans. Clin Plast Surg 1976;3:647-652
25. Shaw GM, Lammer EJ, Wasserman C.R., et al. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995;346:393-396
26. Badovinac RI, Werler MM, Williams P.L., et al. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 2007;79:8-15
27. Wilcox AJ, Lie RT, Solvoll K, et al. Folic acid supplements and risk for facial clefts: national population based case-control study. BMJ 2007;334:464
28. Cao W, Strnatka D, McQueen C.A., et al. N-acetyltransferase 2 activity and folate levels. Life Sci 2010;86:103-106
29. Wolff GL, Rodell RL, Moore S.R., et al. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998;12:949-947
30. Tremolizzo L, Carboni G, Ruzicka W.B., et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci 2002;99:17095-17100
31. Laurence KM, James N, Miller M.H., et al. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981;282:1509-1511
32. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835
33. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci 2002;99:5606-5611
34. van Rooij IALM, Vermeij-Keers C, Kluijtmans LAJ, et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 2003; 157: 583-591
35. Kaartinen V, Voncken JW, Shuler C, et al. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995;11: 415-421
36. Satokata I, Maas R. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 1994;6:348-356
37. Cooney CA, Dave AA, Wolff GL Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002;132:2393S-2400S
38. El-Maarri O. Methods: DNA methylation. Adv Exp Med Biol 2003;544: 197-204
39. Juriloff DM. Genetic analysis of the construction of the AEJ.A congenic strain indicates that nonsyndromic CL(P) in the mouse is caused by two loci with epistatic interaction. J Craniofac Genet Dev Biol 1995;15:1-12
40. Juriloff DM, Mah DG The major locus for multifactorial nonsyndromic cleft lip maps to mouse chromosome 11. Mamm Genome 1995;6: 63-69
41. Juriloff DM, Harris MJ, Brown CJ Unravelling the complex genetics of cleft lip in the mouse model. Mamm Genome 2001;12:426-435
42. Juriloff DM, Harris MJ, Dewell SL A digenic cause of cleft lip in A-strain mice and definition of candidate genes for the two loci. Birth Defects Res A Clin Mol Teratol 2004;70:509-518
43. Juriloff DM, Harris MJ, Dewell S.L., et al. Investigations of the genomic region that contains the clf1 mutation, a causal gene in multifactorial cleft lip and palate in mice. Birth Defects Res A Clin Mol Teratol 2005;73:103-113
44. Juriloff DM, Harris MJ, McMahon A.P., et al. Wnt9b is the mutated gene involved in multifactorial nonsyndromic cleft lip with or without cleft palate in A/WySn mice, as confirmed by a genetic complementation test. Birth Defects Res A Clin Mol Teratol 2006;76:574-579
45. Lan Y, Ryan RC, Zhang Z, et al. Expression of Wnt9b and activation of canonical Wnt signaling during midfacial morphogenesis in mice. Dev Dyn 2006;235:1448-1454
46. Druker R, Whitelaw E. Retrotransposon-derived elements in the mammalian genome: a potential source of disease. J Inherit Metab Dis 2004;27:319-330
47. Whitelaw E, Martin DI Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 2001;27:361-365
48. Shi M, Christensen K, Weinberg C.R., et al. Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants. Am J Hum Genet 2007;80:76-90
49. Carinci F, Pezzetti F, Scapoli L., et al. Recent developments in orofacial cleft genetics. J Craniofac Surg 2003;14:130-143
50. Prescott NJ, Winter RM, Malcolm S. Maternal MTHFR genotype contributes to the risk of non-syndromic cleft lip and palate. J Med Genet 2002;39:368-369
51. Pezzetti F, Martinelli M, Scapoli L., et al. Maternal MTHFR variant forms increase the risk in offspring of isolated nonsyndromic cleft lip with or without cleft palate. Hum Mutat 2004;24:104-105
52. Chevrier C, Perret C, Bahuau M., et al. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A 2007;143:248-257